SCHEMBL3125878

SCHEMBL3125878

O=[N+]([O-])c1ccccc1COc1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.68
KDM4A O75164 1/20 0.56
ALDH1A1 P00352 3/20 0.55
TSHR P16473 1/20 0.55
HTT P42858 1/20 0.54
NPC1 O15118 5/20 0.53
RAB9A P51151 5/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
MAPT P10636 1/20 0.53
KMT2A Q03164 3/20 0.50
HPGD P15428 1/20 0.50
MEN1 O00255 1/20 0.50
ATM Q13315 1/20 0.50
CA12 O43570 2/20 0.49
CA9 Q16790 2/20 0.49
RECQL P46063 1/20 0.49
PTGES O14684 1/20 0.48
SYK P43405 1/20 0.47
HTR1A P08908 1/20 0.47
ADRA1D P25100 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9489214 0.88 MAOB (0.72) MAOBKDM4AALDH1A1TSHRHTT
SCHEMBL920836 0.87 MAOB (0.62) MAOBKDM4AALDH1A1TSHRHTT
SCHEMBL7897679 0.87 MAOB (0.62) MAOBKDM4AALDH1A1TSHRHTT
SCHEMBL28376698 0.87 MAOB (0.66) MAOBKDM4AALDH1A1TSHRHTT
SCHEMBL17368204 0.87 MAOB (0.70) MAOBKDM4AALDH1A1TSHRHTT
SCHEMBL6542046 0.87 MAOB (0.70) MAOBKDM4AALDH1A1TSHRHTT
SCHEMBL17554427 0.84 MAOB (0.63) MAOBKDM4AALDH1A1TSHRHTT
SCHEMBL29568730 0.84 NPC1 (0.59) MAOBALDH1A1TSHRHTTNPC1
SCHEMBL18919738 0.84 NPC1 (0.59) MAOBALDH1A1TSHRHTTNPC1
SCHEMBL3497230 0.84 MAOB (0.66) MAOBKDM4ANPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105037197-A Di(4-trifluoromethylbenzyl) azodiformate, intermediate and preparation method of di(4-trifluoromethylbenzyl) azodiformate UNIV ZHEJIANG 2015-11-11 CN disclosed
EP-1865379-B1 Method for resist pattern formation, and process for device prodution CANON KK (JP) 2013-01-16 EP disclosed
CN-101086618-B Photosensitive compound, photosensitive composition, method for resist pattern formation, and process for elements production CANON KK 2012-06-20 CN disclosed
US-7651834-B2 Photosensitive compound, photosensitive composition, method for resist pattern formation, and process for device production CANON KABUSHIKI KAISHA (JP) 2010-01-26 US disclosed
US-7651834-B2 Photosensitive compound, photosensitive composition, method for resist pattern formation, and process for device production CANON KABUSHIKI KAISHA (JP) 2010-01-26 US disclosed
US-20070287105-A1 PHOTOSENSITIVE COMPOUND, PHOTOSENSITIVE COMPOSITION, METHOD FOR RESIST PATTERN FORMATION, AND PROCESS FOR DEVICE PRODUCTION CANON KABUSHIKI KAISHA (JP) 2007-12-13 US disclosed
US-20070287105-A1 PHOTOSENSITIVE COMPOUND, PHOTOSENSITIVE COMPOSITION, METHOD FOR RESIST PATTERN FORMATION, AND PROCESS FOR DEVICE PRODUCTION CANON KABUSHIKI KAISHA (JP) 2007-12-13 US disclosed
EP-1865379-A1 Photosensitive compound, photosensitive composition, method for resist pattern formation, and process for device prodution Canon Kabushiki Kaisha (JP) 2007-12-12 EP disclosed
CN-101086618-A Photosensitive compound, photosensitive composition, method for resist pattern formation, and process for elements production CANON KK (JP) 2007-12-12 CN disclosed
EP-0141389-A2 Process for the production of image-wise structured resists, and dry resist therefor BASF Aktiengesellschaft (DE) 1985-05-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070287105-A1 PHOTOSENSITIVE COMPOUND, PHOTOSENSITIVE COMPOSITION, METHOD FOR RESIST PATTERN FORMATION, AND PROCESS FOR DEVICE PRODUCTION RER1, C1R, CRY2 MAOB 1351/4885KDM4A 1236/4885ALDH1A1 2569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.